• Smile Brands Scoops Up Dentistry of Sarasota

    On December 2, Smile Brands, one of the largest providers of dental support services in the United States, announced its new partnership with Dentistry of Sarasota. Financial terms of the deal were not disclosed. Smile Brands provides business support services to general and multi-specialty dental groups since its founding in 1998. The company... Read More »
  • Ingenovis Health to Acquire HealthCare Support

    Ingenovis Health, Inc., one of the fastest-growing providers of healthcare staffing, announced on November 29 that it has agreed to acquire HealthCare Support, a national healthcare staffing platform providing a full range of customized hiring solutions across the country. Financial terms of the transaction, which is expected to close in the... Read More »
  • Edifecs to Acquire Health Fidelity

    On November 22, Edifecs, Inc. announced that it has signed a definitive agreement to acquire Health Fidelity, a leading provider of risk adjustment solutions for the value-based care era. The acquisition is expected to close in mid-December of this year, pending regulatory approval. Founded in 1996, Edifecs is a premier technology company in the... Read More »
  • Israeli Startup TailorMed Acquires Vivor

    On November 29, TailorMed, a leading financial navigation platform that helps healthcare organizations and patients remove financial barriers to care, announced that it has acquired Vivor, a financial assistance technology platform for healthcare providers and life sciences. The financial terms of the transaction were not disclosed. TailorMed is... Read More »
  • HomeCentris Healthcare Acquires Grace Home Healthcare

    On November 26, HomeCentris Healthcare, LLC announced that it had acquired Grace Home Healthcare, LLC. The deal was closed in October for an undisclosed amount. Headquartered in Owings Mills, Maryland, HomeCentris Healthcare, LLC is an independent home and community-based care organization. It was founded in 2000 and provides its services to... Read More »
The Healthcare SPAC Market

The Healthcare SPAC Market

For the past two years, the healthcare M&A market has seen a surge of deals involving SPACs, or special purpose acquisition companies created solely as a vehicle for emerging companies to go public. These deals, called a de-SPAC transaction, seem to be surfacing once a week in the healthcare market, a trend not unique to this industry either. Here’s how they start: a sponsor company or investor, sometimes a private equity firm or investment firm, creates a public shell company and then raises funds and capital, called a private investment in public equity, or PIPE, under the idea that it will use those funds to find a target private company. Investors can buy into the PIPE at a low... Read More »
The Oncology Institute Goes Public

The Oncology Institute Goes Public

Even SPACs are getting involved in the physician medical group market. The Oncology Institute of Hope and Innovation, the largest community oncology practice in California, just announced it was going public in an $842 million merger with DFP Healthcare Acquisitions Corp. (NASDAQ: DFPH), a SPAC sponsored by an affiliate of Deerfield Management Company, L.P. The Oncology Institute was formed just this past March by a joint venture between Havencrest Healthcare Partners, M33 Growth and ROCA Partners.  The Oncology Institute has more than 80 board-certified hematologists/oncologists spread throughout 50 offices in Arizona, California and... Read More »
The Healthcare SPAC Market

Pear Therapeutics Goes Public

Another week, another SPAC deal. Pear Therapeutics, Inc., a leader in prescription digital therapeutics (PDTs), has announced it is merging with Thimble Point Acquisition Corp. (NASDAQ: THMA), a special purpose acquisition company managed by the Pritzker Vlock Family Office.  Pear develops clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. The combined business is expected to have a pro forma equity value of approximately $1.6 billion.  The new company, Pear Holding Corp., secured a $125 million PIPE from investors including 5AM Ventures, Arboretum... Read More »
P3 Health Partners Goes Public

P3 Health Partners Goes Public

The private equity-backed P3 Health Partners is going public in a multi-billion-dollar merger with a SPAC.  P3 Health Partners is merging with Foresight Acquisition Corp. (NASDAQ: FORE), and the combined company will have an estimated post-transaction enterprise value of $2.3 billion with an estimated equity value of $2.4 billion from the contribution of at least $180 million in cash proceeds from the transaction. P3 Health Partners was a portfolio company of Chicago Pacific Founders, which is exiting its investment in the company.   P3 Health Partners is a patient-centered and physician-led population health management company that supports providers, physicians and practices as they... Read More »

Science 37 Goes Public in SPAC Deal

Another week, another SPAC deal. This time, Science 37, Inc. is merging with LifeSci Acquisition II Corp. (NASDAQ: LSAQ), a special purpose acquisition company (SPAC) targeting the biopharma, medical technology, digital health and healthcare services sectors. The transaction values Science 37 at a total enterprise value of $1.05 billion and a fully distributed equity value of approximately $1.3 billion at signing. Science 37 shareholders could also get $125 million in achievement milestones.  Science 37 developed the Decentralized Clinical Trial Operating System, which provides workflow coordination, evidence generation and data synchronization, allowing companies to conduct fully... Read More »
Better Therapeutics Goes Public

Better Therapeutics Goes Public

A San Francisco-based cognitive therapy company is going public through a SPAC. Better Therapeutics, Inc. is merging with Mountain Crest Acquisition Corp II (NASDAQ: MCAD), a publicly traded special purpose acquisition corporation. The deal is valued at $187 million, and existing shareholders will roll over 100% of their equity into the equity of the combined company. Better Therapeutics is a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases. The company’s platform blends clinical, behavioral, and psychological inputs into a series of therapy lessons and skill-building modules designed to isolate... Read More »